LEVERNA THERAPEUTICS Trademark
Trademark Overview
On Wednesday, July 19, 2023, a trademark application was filed for LEVERNA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LEVERNA THERAPEUTICS trademark a serial number of 98092622. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Fosun Pharma USA Inc.. The LEVERNA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
General Information
| Serial Number | 98092622 |
| Word Mark | LEVERNA THERAPEUTICS |
| Filing Date | Wednesday, July 19, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, August 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 12, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the word LEVERNA in gradient blue and gradient gray stylized font, wherein the letters E, V, and E comprise a stylized electrocardiogram symbol, all above the word THERAPEUTICS in smaller gray stylized font. Areas in white are for background only and are not claimed as part of the mark. |
| Indication of Colors claimed | The color(s) blue and gray is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 17, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Fosun Pharma USA Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08540 |
| Party Name | Fosun Pharma USA Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08540 |
Trademark Events
| Event Date | Event Description |
| Saturday, July 22, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 18, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, January 30, 2024 | ASSIGNED TO EXAMINER |
| Thursday, February 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 27, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, August 27, 2024 | SOU EXTENSION 1 FILED |
